文献速递生殖医学

母亲年龄与体重指数对体外受精后累积活产率的联合影响

The combined impact of maternal age and body mass index on cumulative live birth following in vitro fertilization.
PubMed 文献 · Am J Obstet Gynecol · 2019-06-01

本研究利用美国辅助生殖技术临床结局报告系统2014年1月至2015年12月的回顾性数据,纳入51959个首次新鲜自体卵母细胞周期及16067个后续冻融胚胎移植周期。结果显示植入率、临床妊娠率和累积活产率随体重指数和年龄增加而下降,流产率随二者增加而上升;在较高年龄,年龄相关生育力下降对累积活产率的影响大于体重指数。

要点

  • 植入率、临床妊娠率、累积活产率随体重指数和年龄增加而下降,线性趋势P<.001。
  • 流产率随体重指数和年龄增加而上升,线性趋势P<.001。
  • 较高年龄时年龄相关生育力下降对累积活产率的影响大于体重指数。

核心结论

  • 年龄相关生育力下降在较高年龄对累积活产率的影响大于体重指数,提示年龄较大的超重或肥胖女性在体外受精前花时间降低体重指数可能有害。
  • 在体外受精前为减重而推迟受孕应结合年龄与体重指数综合考虑。

研究设计与样本

  • 回顾性研究,使用2014年1月至2015年12月美国辅助生殖技术临床结局报告系统的关联新鲜与冻融周期数据,覆盖美国>90%的体外受精周期。
  • 纳入51959个首次新鲜自体卵母细胞周期和16067个后续冻融胚胎移植周期。
  • 采用泊松回归和逻辑回归计算风险比与比值比及95%CI,采用Cox回归计算风险比及95%CI评估累积活产率差异。

主要发现

  • 共有21395例活产,总体累积活产率为每周期起始41.2%。
  • 植入率、临床妊娠率和累积活产率随体重指数和年龄增加而下降,流产率随体重指数和年龄增加而上升,线性趋势P<.001。
  • 体重指数对活产的影响在较年轻年龄大于较年长年龄。

关键数值与推荐

  • 总体累积活产率为每周期起始41.2%。
  • 植入率、临床妊娠率、累积活产率随体重指数和年龄增加而下降,流产率随二者增加而上升,线性趋势P<.001。

临床怎么用

  • 作者认为,对年龄较大的超重或肥胖女性,在体外受精前花时间降低体重指数可能有害。
  • 作者认为,在体外受精前为减重而推迟受孕应结合年龄与体重指数综合考虑。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is critical to evaluate the combined impact of age and body mass index on the cumulative likelihood of live birth following in vitro fertilization, as achieving a lower body mass index before infertility treatment often is recommended for women with overweight and obesity. It is important to consider whether achieving a particular body mass index, thus resulting in an older age at in vitro fertilization cycle start, is beneficial or harmful to the likelihood of live birth. OBJECTIVES: To evaluate the combined impact of age and body mass index on the cumulative live birth rate following in vitro fertilization to inform when delaying in vitro fertilization treatment to achieve a lower body mass index may be beneficial or detrimental to the likelihood of live birth. STUDY DESIGN: This is a retrospective study using linked fresh and cryopreserved/frozen cycles from January 2014 to December 2015 from the Society for Reproductive Technology Clinic Outcome Reporting System, representing >90% of in vitro fertilization cycles performed in the United States. The primary outcome was live birth as measured by cumulative live birth rate. Secondary outcomes included implantation rate, clinical pregnancy rate, and miscarriage rate. Poisson and logistic regression were used to calculate risk and odds ratios with 95% confidence intervals to determine differences in implantation, clinical pregnancy, and miscarriage, as appropriate, among first fresh in vitro fertilization cycles compared across age (years) and body mass index (kg/m2) categories. Cox regression was used to calculate hazard ratios with 95% confidence intervals to determine differences in the cumulative live birth rate using fresh plus linked frozen embryo transfer cycles. RESULTS: There were 51,959 first fresh cycles using autologous eggs and 16,067 subsequent frozen embryo transfer cycles. There were 21,395 live births, for an overall cumulative live birth rate of 41.2% per cycle start. The implantation rate, clinical pregnancy rate, and cumulative live birth rate decreased with increasing body mass index and age, and the miscarriage rate increased with increasing body mass index and age (linear trend P<.001 for all). Body mass index had a greater influence on live birth at younger ages as compared with older ages. CONCLUSIONS: Age-related decline in fertility has a greater impact than body mass index on the cumulative live birth rate at older ages, suggesting that taking time to achieve lower body mass index before in vitro fertilization may be detrimental for older women with overweight or obesity. Delaying conception to lose weight before in vitro fertilization should be informed by the combination of age and body mass index.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Goldman RH, Farland LV, Thomas AM, et al. The combined impact of maternal age and body mass index on cumulative live birth following in vitro fertilization. Am J Obstet Gynecol. 2019. PMID: 31163133. doi:10.1016/j.ajog.2019.05.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。